Great news for @AmadeusCapital backed company @Synthace on its series B with $25.6m investment led by @HorizonsHK to accelerate biotechnology and enable faster scientific breakthroughs https://t.co/JQXR7g8a9z

Congratulations to Amadeus-backed biotech @synthace on its funding round, glad that @HorizonsHK shares our vision for this great company https://t.co/mAsP39ydDK